01—Abstract
Summary
Summary of the 8-K filed February 26, 2025. Cited figures are marked; the original filing is the authoritative source.
Amcor plc (NYSE: AMCR, ASX: AMC) disclosed that its shareholders overwhelmingly approved the Share Issuance Proposal at an Extraordinary General Meeting held February 25, 2025, clearing the shareholder vote condition for its proposed combination with Berry Global Group (NYSE: BERY), announced November 19, 2024.
The approval was strong: 1,033,162,281 votes for, 2,689,594 against, and 1,764,691 abstentions, with no broker non-votes. Per the accompanying press release, more than 71%a of Amcor's outstanding shares were present or represented, and over 99% of those voted in favor. Berry's shareholders also approved the deal, with more than 83% of its outstanding shares represented and over 98% of those voting in favor.
Because the adjournment proposal was not needed, it was not voted on. The companies frame the combination as creating a global leader in consumer and healthcare packaging, with management citing faster growth, portfolio refinement, and $650 millionb of identified synergies. Amcor CEO Peter Konieczny and Berry CEO Kevin Kwilinski both emphasized the strategic rationale of serving customers better and operating globally at a scale neither company could reach alone.
The companies expect the transaction to close in mid-calendar 2025, subject to remaining closing conditions, including regulatory approvals. For investors, the key takeaway is that the largest remaining shareholder hurdle has been cleared, reducing near-term deal-completion uncertainty.
Investors should still weigh the risks flagged in the forward-looking statements, including regulatory approval, integration execution, the realization of synergies, litigation, and the combined company's indebtedness after closing. The $650 millionc synergy figure is management's estimate and is described as a non-GAAP, illustrative measure subject to significant assumptions.
02—Key points
Key Highlights
- Amcor shareholders approved the Share Issuance Proposal at the February 25, 2025 Extraordinary General Meeting, with 1,033,162,281 votes for (over 99% of votes cast) versus 2,689,594 against and 1,764,691 abstentions.
- Berry Global shareholders also approved the combination at their separate meeting, with more than 98% of votes cast in favor, satisfying the shareholder vote condition for the deal.
- Turnout was strong: more than 71% of Amcor's outstanding shares and more than 83% of Berry's were present or represented by proxy.
- Management projects $650 million of identified synergies and expects faster growth from the combined portfolio.
- The transaction is expected to close in mid-calendar 2025, subject to remaining closing conditions, including regulatory approvals.
- The adjournment proposal was not voted on because sufficient votes were obtained for the Share Issuance Proposal.
- Key risks remain, including regulatory approval, integration execution, synergy realization, litigation, and post-closing indebtedness.
03—Questions
Frequently Asked Questions
Did shareholders approve the Amcor and Berry combination?
Yes. Amcor shareholders approved the Share Issuance Proposal by a wide margin at the February 25, 2025 Extraordinary General Meeting, and Berry shareholders also approved the combination at their separate meeting. This satisfies the shareholder vote condition for the deal.
How much support did the share issuance proposal receive?
The proposal received 1,033,162,281 votes for, 2,689,594 against, and 1,764,691 abstentions, with no broker non-votes. According to the press release, more than 99% of the Amcor shares voted were cast in favor.
When is the Amcor-Berry transaction expected to close?
The companies expect the combination to close in mid-calendar 2025, subject to the remaining closing conditions, which include regulatory approvals. Shareholder approval removes one of those conditions but does not guarantee completion.
What financial benefits do management expect from the deal?
Management cites $650 million of identified synergies and expects faster growth and portfolio refinement for the combined company. These are management estimates, described in the filing as illustrative, non-GAAP measures that depend on significant assumptions and may not be realized as expected.
What risks should investors still consider?
Investors should consider the risk that closing conditions, including regulatory approvals, are not satisfied on time or at all, along with integration challenges, the possibility that anticipated synergies are not realized, litigation, management distraction, potential customer and personnel attrition, and the combined company's post-closing indebtedness.
04—Continue